Advertisement
Screener

BIOMERICA INC (BMRA) Form 10-K: Annual report

BIOMERICA INC Form 10-K: Annual report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-31: Form 10-K; Period of report 2026-05-31; Description 10-K; Document form10-k.htm.
  • 2025-08-29: Form 10-K; Period of report 2025-05-31; Description 10-K; Document form10-k.htm.
  • 2024-08-28: Form 10-K; Period of report 2024-05-31; Description Annual report; Document form10-k.htm.
  • 2023-08-25: Form 10-K; Period of report 2023-05-31; Description Annual report; Document form10-k.htm.
FiledFormPeriod of reportDescriptionDocument
2026-08-3110-K2026-05-3110-Kform10-k.htm
2025-08-2910-K2025-05-3110-Kform10-k.htm
2024-08-2810-K2024-05-31Annual reportform10-k.htm
2023-08-2510-K2023-05-31Annual reportform10-k.htm
2022-08-2910-K2022-05-31FORM 10-Kbmra-20220531.htm
2021-08-2710-K2021-05-31FORM 10-Kform10k.htm
2020-08-3110-K2020-05-31FORM 10-Kform10k.htm
2019-08-2910-K2019-05-31FORM 10-Kform10k.htm
2018-08-2910-K2018-05-31FORM 10-Kform10k.htm
2017-08-2910-K2017-05-31FORM 10-Kform10K.htm
2016-08-2910-K2016-05-31FORM 10-Kform10k.htm
2015-08-3110-K2015-05-31FORM 10-Kform10k.htm
2014-08-2910-K2014-05-31FORM 10-Kform10k.htm
2013-08-2910-K2013-05-31FORM 10-Kbmra_10k1.htm
2012-08-2910-K2012-05-31FORM 10-Kbiomerica201210k.htm
2011-08-3010-K2011-07-29FORM 10-Kf10kwithfinancials4.htm
2010-08-3010-K2010-05-31BIOMERICA 10-Kbiomerica_10k.htm
2009-08-3110-K2009-05-31FORM 10-Kbiomerica_10k-053109.txt

Similar stocks

Stock NameCountryMarket CapPE Ratio
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92